CBI's 12th Annual Pharmaceutical Compliance Conference
Lewis Morris, former Chief Counsel to the Inspector General, U.S. Department of Health & Human Service; Senior Counsel, LeClairRyan, analysis on SamplifyRx
Download his analysis on the OIG and CMS copayment coupon report using SamplifyRx
Fill out the form below to get the analysis
Pharmaceutical manufacturers that offer copayment coupons may be subject to sanctions if they fail to take appropriate steps to ensure that such coupons do not induce the purchase of Federal health care program items or services...
OIG report “Manufacturer Safeguards May Not Prevent Copayment Coupon Use for Part D Drugs”
Schedule a live demo of SamplifyRx today!
Contact Scott Pribyl, CEO - scott@SamplifyRx.com - (913) 314-8825
